Search

Search

Home
...
Research Domains Biomedical and Clinical Sciences Oncology and Carcinogenesis Predictive and prognostic markers
Research Domains
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Predictive and prognostic markers
Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy

Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy

Anna Torrent ^1,2, Mireia Morgades ^3,4, Gloria Iacoboni ⁵, Juan Luis Reguera ⁶, Mi Kwon ⁷, Lucia López Corral ⁸, Rafael Hernani ⁹, Valentín Ortiz-Maldonado ¹⁰, Jaime Sanz ¹¹, Ana Carolina Caballero Gonzalez ¹², Luisa Guerra ¹³, José María Sánchez Pina ¹⁴, Alberto Mussetti ¹⁵, Alejandro Martin Garcia-Sancho ⁸, Mariana Bastos-Oreiro ¹⁶, Javier Delgado ⁷, Cecilia Carpio ⁵, Juan-Manuel Sancho ^3,4, Antonio Pérez-Martinez ¹⁷, Pere Barba ⁵

Anna Torrent ^1,2, Mireia Morgades ^3,4, Gloria Iacoboni ⁵

¹ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Badalona, Spain. atorrent@iconcologia.net.
²Universitat Autònoma de Barcelona, Barcelona, Spain. atorrent@iconcologia.net.
³ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Badalona, Spain.
⁴Universitat Autònoma de Barcelona, Barcelona, Spain.
⁵Hospital Universitari Vall d'Hebron. Universitat Autónoma de Barcelona, Barcelona, Spain.
⁶University Hospital Virgen Del Rocío, Sevilla, Spain.
⁷Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
⁸Hospital Universitario de Salamanca, IBSAL, CIBERONC, Universidad de Salamanca, Salamanca, Spain.
⁹Hospital Clínico de Valencia, Valencia, Spain.
¹⁰Hospital Clinic de Barcelona, Barcelona, Spain.
¹¹Departament de Medicina Universitat de Valencia, CIBERONC, Hospital Universitari i Politècnic La Fe, Instituto Carlos III, Madrid, Spain.
¹²Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
¹³Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain.
¹⁴Hospital Universitario 12 de Octubre, Madrid, Spain.
¹⁵Institut Català d'Oncologia-Hospitalet, IDIBELL, Barcelona, Spain.
¹⁶Hospital General Gregorio Marañón, Madrid, Spain.
¹⁷Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.

⁰ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Badalona, Spain. atorrent@iconcologia.net.

Bone Marrow Transplantation +

|

October 1, 2025

|

October 1, 2025

Related Experiment Videos

Contact us if these videos are not relevant.

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [¹⁸F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

See all related videos

Summary

No abstract available on PubMed

Related Experiment Videos

Contact us if these videos are not relevant.

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [¹⁸F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

See all related videos

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies